Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury
Archives of Biochemistry and Biophysics · 2024
DOI: 10.1016/j.abb.2024.110084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2024. Verfasst von Doaa Emad und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: doaa.roshdy2018@pharm.sohag.edu.eg. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Signal Transduction, Flavonols, NF-kappa B. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 66 Literaturangaben.
Abstract (Originalsprache)
Nuclear factor erythroid factor 2 (Nrf2) is the key regulatory of the antioxidant response elements. Also, Nrf2 interacts with nuclear factor kappa B (NF-ĸB) to inhibit subsequent inflammatory cascade. Activation of Nrf2 signaling ameliorates drug-induced liver injury. Sodium valproate (SVP) is an anti-epilepsy drug with a hepatotoxic adverse effect that restricts its clinical use. In this study, coadministration of Dihydromyricetin (DHM), a natural flavonoid, with SVP to rats upregulated gene expression of Nrf2 and its downstream gene, heme oxygenase 1 (HO-1), while suppressed the Nrf2 repressor, Keap-1. Additionally, DHM led to downregulation of proinflammatory factors in liver tissues, including NF-ĸB, interleukin 1 beta (IL-1β), and tumor necrosis factor alpha (TNF-α). This was accompanied by a decrease in the proapoptotic protein (cleaved caspase-3) expression level. Furthermore, biochemical and histopathological studies showed that DHM treatment improved liver function and lipid profile while decreased inflammatory cell infiltration, congestion, and hepatocellular damage. According to our knowledge, prior research has not examined the protective effect of DHM on the liver injury induced by SVP. Consequently, this study provides DHM as a promising herbal medication that, when used with SVP, can prevent its induced hepatotoxicity owing to its potential anti-oxidative, anti-inflammatory, and anti-apoptotic properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: doaa.roshdy2018@pharm.sohag.edu.eg.
- Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, 61511, Egypt. Electronic address: asmaa_bayoumi@mu.edu.eg.
- Department of Histology and Cell biology, Faculty of Medicine, Sohag University, Sohag, Egypt. Electronic address: Sahermohamed@med.sohag.edu.eg.
- Department of Biochemistry, Faculty of Pharmacy, Sohag University, Sohag, Egypt. Electronic address: doaa.elroby@pharm.sohag.edu.eg.
- Department of Biochemistry, Faculty of Pharmacy, Minia University, El-Minia, 61511, Egypt. Electronic address: shaimaaminia@mu.edu.eg.
Zitieren
APA
Emad, D., Bayoumi, A. M. A., Gebril, S. M., Ali, D. M. E., & Waz, S. (2024). Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury. Archives of Biochemistry and Biophysics. https://doi.org/10.1016/j.abb.2024.110084
Vancouver
Emad D, Bayoumi AMA, Gebril SM, Ali DME, Waz S. Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury. Archives of Biochemistry and Biophysics. 2024. doi:10.1016/j.abb.2024.110084
BibTeX
@article{Emad2024,
author = {Emad, Doaa and Bayoumi, Asmaa M A and Gebril, Sahar M and Ali, Doaa Mohamed Elroby and Waz, Shaimaa},
title = {Modulation of keap-1/Nrf2/HO-1 and NF-ĸb/caspase-3 signaling pathways by dihydromyricetin ameliorates sodium valproate-induced liver injury},
journal = {Archives of Biochemistry and Biophysics},
year = {2024},
doi = {10.1016/j.abb.2024.110084}
}
EUVIMED